Skip to main content

Table 1 Clinical information of training cohort and validation cohort

From: DNA damage repair gene signature model for predicting prognosis and chemotherapy outcomes in lung squamous cell carcinoma

  

TCGA-training cohort

GEO-validation cohort

Gender

Male

373

105

Female

131

121

Age

 < 60

91

96

 >  = 60

404

130

Pathological stage

Stage I

245

168

Stage II

163

58

Stage III

85

-

Stage IV

7

-

unknow

4

-

Survival Status

Alive

304

191

Dead

200

35

T stage

T1 stage

114

-

T2 stage

295

-

T3 stage

71

-

T4 stage

24

-

N stage

N0 stage

320

-

N1 stage

133

-

N2 stage

40

-

N3 stage

5

-

unknow

6

-

M stage

M0

414

-

M1

7

-

unknow

83

-